A number of labs have conducted important studies combining Tet2 deletion with other lesions that frequently co-occur in human AML, such as Dnmt3a as previously mentioned, NRAS and KIT (111, 118, 119). This evidence concerns the gene DNMT3A and acute myeloid leukemia.